COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 1747: Articles 17461-17470  | Next

Worries about COVID-19 infection and psychological distress at work and while commuting
Uehara, M., Ishimaru, T., Ando, H., Tateishi, S., Eguchi, H., Tsuji, M., Mori, K., Matsuda, S., Fujino, Y.
10.1101/2021.02.16.21250657 — Posted: 2021-02-19
Incidence and Outcomes of Pulmonary embolism among hospitalized COVID-19 patients
Badr, O., Alwafi, H., Elrefaey, W., Naser, A. Y., Shabrawishi, M.
10.1101/2021.02.16.21251676 — Posted: 2021-02-19
When efficacy and adherence conflict: preferences and patterns of response to public health advice during the COVID-19 pandemic
Nov, O., Dove, G., Balestra, M., Lawrence, K., Mann, D., Wiesenfeld, B.
10.1101/2021.02.15.21251765 — Posted: 2021-02-19
SEIR Filter: A Stochastic Model of Epidemic
Smid, M., Berec, L., Kubena, A. A., Levinsky, R., Trnka, J., Tucek, V., Zajicek, M.
10.1101/2021.02.16.21251834 — Posted: 2021-02-19
Mortality in COVID-19 amongst women on Hormone Replacement Therapy or Combined Oral Contraception: A cohort study
Dambha-Miller, H., Hinton, W., Joy, M., Feher, M., de Lusignan, S.
10.1101/2021.02.16.21251853 — Posted: 2021-02-19
Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2
Kissler, S. M., Fauver, J. R., Mack, C., Tai, C., Breban, M., Watkins, A. E., Samant, R., Anderson, D., Ho, D., Grubaugh, N. D., Grad, Y.
10.1101/2021.02.16.21251535 — Posted: 2021-02-19
Circulatory Cytokines and Chemokines Profile in Human Coronaviruses: A systematic review and meta-analysis
Zawawi, A., Naser, A. Y., Alwafi, H., Minsahwi, F.
10.1101/2021.02.16.21251673 — Posted: 2021-02-19
Size and duration of COVID-19 clusters go along with a high SARS-CoV-2 viral load : a spatio-temporal investigation in Vaud state, Switzerland
Ladoy, A., Opota, O., Carron, P.-N., Guessous, I., Vuilleumier, S., Joost, S., Greub, G.
10.1101/2021.02.16.21251641 — Posted: 2021-02-19
The rise of SARS-CoV-2 variant B.1.1.7 in Israel intensifies the role of surveillance and vaccination in elderly
Munitz, A., Yechezkel, M., Dickstein, Y., Yamin, D., Gerlic, M.
10.1101/2021.02.16.21251819 — Posted: 2021-02-19 Discussion: Onsite
SARS-CoV-2 detection by rRT-PCR on self-collected anterior nares swabs or saliva compared with clinician-collected nasopharyngeal swabs--Denver and Atlanta, August--November, 2020
Marx, G. E., Smith-Jeffcoat, S. E., Biggerstaff, B. J., Koh, M., Nawrocki, C. C., Travanty, E. A., Totten, S. E., Scott, T., Chavez-Van De Hey, J., Carlson, J. J., Wendel, K. A., Burakoff, A. W., Hoffman, A., Rebolledo, P. A., Schechter, M. C., Wang, Y. F., Moore, B. L., Atallah, H. Y., Sexton, D. J., Hartloge, C., Paulick, A., Miller, H. K., Sleweon, S., Rosetti, R., Shragai, T., O'Laughlin, K., Stewart, R. J., da Silva, J., Biedron, C., CDPHE COVID-19 Laboratory Response Team, , CDC COVID-19 Response GA-10 Team, , CDC COVID-19 Response Lab Task Force, , Thomas, J. D., Kirking, H. L., Tate, J. E., Rowan, S. E.
10.1101/2021.02.16.21251521 — Posted: 2021-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).